Work

A Safety Monitoring Framework for Critical Care Trials of Agents with Potential to Lower Blood Pressure

Year: 2022

Type: conference-abstract

DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2441

Authors: I. Peltan, C.E. Barkauskas, S.S. Mistry, B. Grund, M. Teitelbaum, C.F. Oldmixon, M.A. Matthay, V.L. Kan, A.G. Babiker, N.A. Bickell, E.S. Higgs, A.C. Gelijns, J.D. Lundgren, J.D. Neaton, B.T. Thompson, S.M. Brown, Therapeutics for Severely Ill Inpatients with COVID-19 (TESI

Institutions: University of Utah, Intermountain Medical Center, Duke University, Duke Medical Center, University of Minnesota, Leidos Biomedical Research Inc. (United States), Massachusetts General Hospital, University of California, San Francisco, George Washington University, Washington DC VA Medical Center, University College London, Icahn School of Medicine at Mount Sinai, National Institute of Allergy and Infectious Diseases, Rigshospitalet

Language: English

Topic: Statistical Methods in Clinical Trials

Subfield: Statistics and Probability

Field: Mathematics

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4225308007

Cites:

Cited by:

Related to: 10